# Lonza Biologics, Inc. - Inspection Records Source: https://www.keypedia.com/companies/lonza-biologics-inc/f9882ce5-d92a-4c88-916e-8f4e6d1f2aff > Inspection records and compliance data for Lonza Biologics, Inc. in Portsmouth, New Hampshire. Access full analysis and detailed observations. --- ## Details - Name: Lonza Biologics, Inc. - FEI Number: 3001451441 - City: Portsmouth - State: New Hampshire - Country Name: United States - Address Line 1: 101 International Dr - Zip Code: 03801 ## Related Documents - [483 - Lonza Biologics, Inc. - 2026-04-16](https://www.keypedia.com/records/483/lonza-biologics-inc/7b621acc-25b2-419b-b47c-63946c125023) — source: FDA, date: April 16, 2026 - [FDA Inspection 1312718 - Lonza Biologics, Inc. - 2026-04-16](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/ed1a184f-48bf-4bed-8f91-879eb015a451) — source: FDA, date: April 16, 2026 - [FDA Inspection 1312718 - Lonza Biologics, Inc. - 2026-04-16](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/5bbfa47f-509d-40b8-bed0-301a8269c65e) — source: FDA, date: April 16, 2026 - [483 - Lonza Biologics, Inc. - 2026-02-06](https://www.keypedia.com/records/483/lonza-biologics-inc/6673b307-3165-470e-bad9-c55bdebe90ed) — source: FDA, date: February 6, 2026 - [FDA Inspection 1304046 - Lonza Biologics, Inc. - 2026-02-06](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/f423c98c-ca42-48ca-aa3a-6cfd4e863518) — source: FDA, date: February 6, 2026 - [FDA Inspection 1304046 - Lonza Biologics, Inc. - 2026-02-06](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/6829aae3-393f-4927-a6eb-2cdeb1a281e4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 6, 2026 - [483 - Lonza Biologics, Inc. - 2025-06-06](https://www.keypedia.com/records/483/lonza-biologics-inc/7e2c12cc-7bee-4578-9e3c-7e55036f3e8e) — source: FDA, date: June 6, 2025 - [FDA Inspection 1269735 - Lonza Biologics, Inc. - 2025-06-06](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/764dd13f-c7b5-4dc4-a6d1-c66b08767132) — source: FDA, date: June 6, 2025 - [FDA Inspection 1246345 - Lonza Biologics, Inc. - 2024-07-12](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/f5daf7e2-8fee-4f83-b20e-a0a824ab2a8c) — source: FDA, date: July 12, 2024 - [483 - Lonza Biologics, Inc. - 2024-03-07](https://www.keypedia.com/records/483/lonza-biologics-inc/a5417b6a-1ebe-4cd5-8ba7-eae412f0931f) — source: FDA, date: March 7, 2024 - [FDA Inspection 1232144 - Lonza Biologics, Inc. - 2024-03-07](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/27bf4b1b-9774-4fae-ab31-cccbdc39d416) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 7, 2024 - [FDA Inspection 1232144 - Lonza Biologics, Inc. - 2024-03-07](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/d26d327b-7e5e-44dc-a11f-5a0ed641f62d) — classification: No Action Indicated (NAI), source: FDA, date: March 7, 2024 - [483 - Lonza Biologics, Inc. - 2023-07-21](https://www.keypedia.com/records/483/lonza-biologics-inc/868ee773-89d9-4285-aa55-f226970279fa) — source: FDA, date: July 21, 2023 - [FDA Inspection 1210690 - Lonza Biologics, Inc. - 2023-07-21](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/fa6c0e5e-762e-44f9-b5cd-483c8003242f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 21, 2023 - [483 - Lonza Biologics, Inc. - 2021-10-22](https://www.keypedia.com/records/483/lonza-biologics-inc/6e82b09e-669e-408f-9fb6-6063c2bbc0b0) — source: FDA, date: October 22, 2021 - [EIR - Lonza Biologics, Inc. - 2020-11-03](https://www.keypedia.com/records/eir/lonza-biologics-inc/3d44ec3c-8d8b-4191-86f7-37a1e679a7ab) — source: FDA, date: November 3, 2020 - [483 - Lonza Biologics, Inc. - 2020-11-03](https://www.keypedia.com/records/483/lonza-biologics-inc/1c4dc8ba-78a2-4438-b100-d4cfaa927f37) — source: FDA, date: November 3, 2020 - [FDA Inspection 1028939 - Lonza Biologics, Inc. - 2017-09-21](https://www.keypedia.com/records/fda_inspections/lonza-biologics-inc/db419acd-b0d3-4e28-a649-9f42bc3edea4) — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2017 ## Related Companies - [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/e097960f-98b1-47f2-877c-d588005879b6) - [MedImmune U.K. Limited](https://www.keypedia.com/companies/medimmune-uk-limited/fbddd1ed-5a0c-4c65-a48e-bb2af79482ed) - [Lotte Biologics USA, LLC](https://www.keypedia.com/companies/lotte-biologics-usa-llc/97010853-9f18-4cf1-8766-55df585a2452) - [Divi's Laboratories Ltd. (Unit II)](https://www.keypedia.com/companies/divis-laboratories-ltd-unit-ii/b2498cb9-d277-498a-b32b-037e04f6feaf) - [Cipla Limited](https://www.keypedia.com/companies/cipla-limited/cefc1473-6852-4af7-b996-0730dc0834bb) - [Protherics UK Limited](https://www.keypedia.com/companies/protherics-uk-limited/ad10cdb3-3b0a-464d-bc88-0dee94941d89) - [Neuland Laboratories Limited (Unit II)](https://www.keypedia.com/companies/neuland-laboratories-limited-unit-ii/59503c03-6ca1-4d3b-b4fe-ddbe511d8126) - [Shanghai SynTheAll Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shanghai-syntheall-pharmaceutical-co-ltd/fa409b87-68e2-4a70-bda1-c33e8d807977) - [Laurus Labs Limited](https://www.keypedia.com/companies/laurus-labs-limited/de6ba41e-9c9b-4d3d-bd7a-ccbc275c080d) - [Apitoria Pharma Private Limited](https://www.keypedia.com/companies/apitoria-pharma-private-limited/c56154eb-1a77-4f64-9db0-4ae380d6b65e) ## Related Officers - [Senior Regulatory Specialist](https://www.keypedia.com/people/wayne-e-seifert/e92e1f10-c61e-4b08-9156-25907e5e2942) - [Biologist](https://www.keypedia.com/people/jacek-cieslak/59683a5f-277f-41b8-be10-0dc82b7596f3) - [FDA_PERSONNEL](https://www.keypedia.com/people/pete-amin/7f032e7a-1dfc-4240-ba8d-2bba5f7e5b6b) - [Obinna R. Echeozo](https://www.keypedia.com/people/obinna-r-echeozo/ac368e15-21ee-408f-8b5e-7a9dd0aa3408)